New X-Ray tracking could sharpen prostate cancer radiation

NCT ID NCT02397317

Completed Disease control Sponsor: University of Sydney Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new X-ray monitoring technique (KIM) during prostate cancer radiation therapy. The goal was to see if it helps doctors aim more precisely at the tumor while reducing harm to healthy tissue. 49 men with low- or intermediate-risk prostate cancer took part. The approach may lead to fewer side effects and better outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Calvary Mater Newcastle

Newcastle, New South Wales, 2298, Australia
Liverpool Cancer Therapy Centre

Sydney, New South Wales, 1871, Australia
Peter MacCallum Cancer Centre

Melbourne, Victoria, 3000, Australia
Royal North Shore Hospital

Sydney, New South Wales, 2065, Australia
The Crown Princess Mary Cancer Centre Westmead

Sydney, New South Wales, 2145, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.